Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Hopeforthebeston Mar 27, 2024 12:08pm
110 Views
Post# 35955706

RE:RE:AEZS Q4

RE:RE:AEZS Q4Gagnon should once again remind Czo shareholders why it is a benifit for shareholders to merger with Aezs. It is clearly evident that Aezs did not want the 2023 4th qrtr and yearend report to go out before the vote as the results are absolutely PATHETIC with zero hope of improvement in the near future. AEZS is bleeding money and will soon add Czo to the wounded fold. 

I also wonder what the 4th qrtr and yearend looks like for Czo and we have had already 4 qrtrs of poor performance, and no moving forward onthe socalled pipeline.

I also wonder if someone would approach the Canadian Securities to investigate the withholding of information and the dealy in getting out the merger infromation in a timely manner.

Just remember what gagnon has done to Czo he has been doing to Aezs for 25 years and will now has a chance to ruin another company with NoShowRonnie help. Incompetence at the highest level. 
<< Previous
Bullboard Posts
Next >>